Literature DB >> 36107172

Error in Results and Table 1.

.   

Abstract

Entities:  

Year:  2022        PMID： 36107172      PMCID： PMC9478777          DOI： 10.1001/jamaoncol.2022.4366

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   33.006


× No keyword cloud information.
  1 in total

1.  Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer: A Phase 1/2 Open-label Nonrandomized Clinical Trial.

Authors:  Caicun Zhou; Suresh S Ramalingam; Tae Min Kim; Sang-We Kim; James Chih-Hsin Yang; Gregory J Riely; Tarek Mekhail; Danny Nguyen; Maria R Garcia Campelo; Enriqueta Felip; Sylvie Vincent; Shu Jin; Celina Griffin; Veronica Bunn; Jianchang Lin; Huamao M Lin; Minal Mehta; Pasi A Jänne
Journal:  JAMA Oncol       Date:  2021-12-16       Impact factor: 33.006
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.